Article info
Basic and translational research
Extended report
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
- Correspondence to Professor Pascal Richette, Fédération de Rhumatologie, Centre Viggo Petersen, Hôpital Lariboisière, 2 rue Ambroise Paré, Paris 75010, France; pascal.richette{at}aphp.fr
Citation
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis
Publication history
- Received April 21, 2016
- Revised August 25, 2016
- Accepted October 9, 2016
- First published October 27, 2016.
Online issue publication
March 10, 2017
Article Versions
- Previous version (27 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/